- Home
- NIU vs CMPX Comparison
NIU vs CMPX Comparison
Compare NIU & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIU
- CMPX
- Stock Information
- Founded
- NIU 2014
- CMPX 2014
- Country
- NIU China
- CMPX United States
- Employees
- NIU N/A
- CMPX N/A
- Industry
- NIU Auto Manufacturing
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- NIU Consumer Discretionary
- CMPX Health Care
- Exchange
- NIU Nasdaq
- CMPX Nasdaq
- Market Cap
- NIU 216.7M
- CMPX 291.8M
- IPO Year
- NIU 2018
- CMPX N/A
- Fundamental
- Price
- NIU $3.47
- CMPX $2.15
- Analyst Decision
- NIU
- CMPX Strong Buy
- Analyst Count
- NIU 0
- CMPX 8
- Target Price
- NIU N/A
- CMPX $13.13
- AVG Volume (30 Days)
- NIU 1.2M
- CMPX 790.1K
- Earning Date
- NIU 05-19-2025
- CMPX 05-08-2025
- Dividend Yield
- NIU N/A
- CMPX N/A
- EPS Growth
- NIU N/A
- CMPX N/A
- EPS
- NIU N/A
- CMPX N/A
- Revenue
- NIU $477,578,753.00
- CMPX $850,000.00
- Revenue This Year
- NIU $41.32
- CMPX N/A
- Revenue Next Year
- NIU $24.38
- CMPX N/A
- P/E Ratio
- NIU N/A
- CMPX N/A
- Revenue Growth
- NIU 26.51
- CMPX N/A
- 52 Week Low
- NIU $1.65
- CMPX $0.77
- 52 Week High
- NIU $4.90
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- NIU 48.06
- CMPX 60.21
- Support Level
- NIU $3.53
- CMPX $2.06
- Resistance Level
- NIU $4.16
- CMPX $2.23
- Average True Range (ATR)
- NIU 0.32
- CMPX 0.12
- MACD
- NIU -0.01
- CMPX 0.01
- Stochastic Oscillator
- NIU 31.37
- CMPX 73.81
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.